Page 4 - Read Online

Rare Disease and Orphan Drugs Journal

C O N T E N T S

Editorial
1 The discovery of the Papillon-Lefèvre syndrome, a rare cathepsin C related lysosomal disease
Brice Korkmaz, Seda Seren, Elodie Kara, Celia Moss
Rare Dis Orphan Drugs J 2022;1:16. http://dx.doi.org/10.20517/rdodj.2022.26

Review

2 Targeting neutrophil serine proteinases in alpha-1 antitrypsin deficiency
Celine H. Chen, Robert A. Stockley
Rare Dis Orphan Drugs J 2022;1:15. http://dx.doi.org/10.20517/rdodj.2022.18

3 Elastase-dependent congenital neutropenia
Angelika Mazur, Joanna Skrzeczynska-Moncznik, Pawel Majewski, Joanna Cichy
Rare Dis Orphan Drugs J 2023;2:1. http://dx.doi.org/10.20517/rdodj.2022.12

4 Immune cell-derived serine protease as pathogenic drivers of vascular remodeling in pulmonary arterial
hypertension
Izabela Borek, Grazyna Kwapiszewska
Rare Dis Orphan Drugs J 2023;2:5. http://dx.doi.org/10.20517/rdodj.2022.20

5 Neutrophil serine proteases
Marcin Skoreński, Karolina Torzyk, Marcin Sieńczyk
Rare Dis Orphan Drugs J 2023;2:6. http://dx.doi.org/10.20517/rdodj.2022.21

6 Pathogenesis of autoimmune and hereditary pancreatitis with a focus on neutrophil granulocytes and
neutrophil serine proteases
Lukas Zierke, Marcel Gischke, Quang Trung Tran, Ali A. Aghdassi
Rare Dis Orphan Drugs J 2023;2:10. http://dx.doi.org/10.20517/rdodj.2022.17

7 Cathepsin C: structure, function, and pharmacological targeting
Milena Stojkovska Docevska, Marko Novinec
Rare Dis Orphan Drugs J 2023;2:14. http://dx.doi.org/10.20517/rdodj.2023.09